+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DiaSorin SpA (DIA) - Product Pipeline Analysis, 2023 Update

  • PDF Icon

    Company Profile

  • 130 Pages
  • June 2023
  • GlobalData
  • Diasorin
  • ID: 5637106
DiaSorin SpA (DiaSorin) is a medical diagnostics company that is engaged in the development, manufacturwing, and marketing of in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s immunodiagnostic and molecular diagnostics products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases, among others. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, Europe, the Middle East, Africa, and Asia. DiaSorin is headquartered in Saluggia, Piemonte, Italy.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DiaSorin SpA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • DiaSorin SpA Company Overview
  • DiaSorin SpA Company Snapshot
  • DiaSorin SpA Pipeline Products and Ongoing Clinical Trials Overview
  • DiaSorin SpA - Pipeline Analysis Overview
  • Business Description
  • DiaSorin SpA - Key Facts
  • DiaSorin SpA - Major Products and Services
  • DiaSorin SpA Pipeline Products by Development Stage
  • DiaSorin SpA Ongoing Clinical Trials by Trial Status
  • DiaSorin SpA Pipeline Products Overview
  • ARIES - Tuberculosis Assay
  • ARIES - Tuberculosis Assay Product Overview
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay Product Overview
  • Aries LDT Cartridge
  • Aries LDT Cartridge Product Overview
  • Aries V2
  • Aries V2 Product Overview
  • Atlas System - Enteric Assay
  • Atlas System - Enteric Assay Product Overview
  • BCR-ABL ABL Assay
  • BCR-ABL ABL Assay Product Overview
  • BCR-ABL P190 + ABL Assay
  • BCR-ABL P190 + ABL Assay Product Overview
  • BCR-ABL v1.5 Assay
  • BCR-ABL v1.5 Assay Product Overview
  • C-Kit 816 Assay
  • C-Kit 816 Assay Product Overview
  • C-Kit 822 Assay
  • C-Kit 822 Assay Product Overview
  • Companion Diagnostic Device - Alzheimer's Disease
  • Companion Diagnostic Device - Alzheimer's Disease Product Overview
  • Diagnostic Assay - Atypical Pneumonia
  • Diagnostic Assay - Atypical Pneumonia Product Overview
  • Diagnostic Assay - Chronic Kidney Disease
  • Diagnostic Assay - Chronic Kidney Disease Product Overview
  • Diagnostic Assay - Enteric Infection
  • Diagnostic Assay - Enteric Infection Product Overview
  • Diagnostic Assay - Fecal Occult Blood Assay
  • Diagnostic Assay - Fecal Occult Blood Assay Product Overview
  • Diagnostic Assay - Group B Streptococcus Infection
  • Diagnostic Assay - Group B Streptococcus Infection Product Overview
  • Diagnostic Assay - HBsAg High Throughput
  • Diagnostic Assay - HBsAg High Throughput Product Overview
  • Diagnostic Assay - HCV II
  • Diagnostic Assay - HCV II Product Overview
  • Diagnostic Assay - HSV M + cntr
  • Diagnostic Assay - HSV M + cntr Product Overview
  • Diagnostic Assay - Lactoferrin Assay
  • Diagnostic Assay - Lactoferrin Assay Product Overview
  • Diagnostic Assay - Lipase Assay
  • Diagnostic Assay - Lipase Assay Product Overview
  • Diagnostic Assay - MRSA
  • Diagnostic Assay - MRSA Product Overview
  • Diagnostic Assay - Mycoplasma Genitalium Infection
  • Diagnostic Assay - Mycoplasma Genitalium Infection Product Overview
  • Diagnostic Assay - RVP II
  • Diagnostic Assay - RVP II Product Overview
  • Diagnostic Assay - Streptococcus Pneumonia
  • Diagnostic Assay - Streptococcus Pneumonia Product Overview
  • Diagnostic Assay - Vaginosis
  • Diagnostic Assay - Vaginosis Product Overview
  • Diagnostic Assay - Vector Borne Diseases
  • Diagnostic Assay - Vector Borne Diseases Product Overview
  • Diagnostic Test - HEV IgG
  • Diagnostic Test - HEV IgG Product Overview
  • Diagnostic Test - HEV IgM
  • Diagnostic Test - HEV IgM Product Overview
  • Estradiol II Assay
  • Estradiol II Assay Product Overview
  • Fungal Panel Assay
  • Fungal Panel Assay Product Overview
  • H.Influenza B Assay
  • H.Influenza B Assay Product Overview
  • Human Herpes Virus 8 IgG IFA Assay
  • Human Herpes Virus 8 IgG IFA Assay Product Overview
  • LAMP CBF-MYH D Assay
  • LAMP CBF-MYH D Assay Product Overview
  • LAMP CBF-MYH E Assay
  • LAMP CBF-MYH E Assay Product Overview
  • LAMP VCA IgA Assay
  • LAMP VCA IgA Assay Product Overview
  • LIAISON - Chlamydia P. IgA Assay
  • LIAISON - Chlamydia P. IgA Assay Product Overview
  • LIAISON - Chlamydia P. IgG Assay
  • LIAISON - Chlamydia P. IgG Assay Product Overview
  • LIAISON - High Sclerostin Assay
  • LIAISON - High Sclerostin Assay Product Overview
  • LIAISON - Hyperphosphate High Bone Turnover Assay
  • LIAISON - Hyperphosphate High Bone Turnover Assay Product Overview
  • LIAISON - Hyperphosphate Low Bone Turnover Assay
  • LIAISON - Hyperphosphate Low Bone Turnover Assay Product Overview
  • LIAISON IAM - Acute Lymphoblastic Leukemia Test
  • LIAISON IAM - Acute Lymphoblastic Leukemia Test Product Overview
  • LIAISON IAM - Acute Promyelocytic Leukemia Test
  • LIAISON IAM - Acute Promyelocytic Leukemia Test Product Overview
  • LIAISON IAM - EBV Assay
  • LIAISON IAM - EBV Assay Product Overview
  • LIAISON IAM - Myeloproliferative Neoplasm Assay
  • LIAISON IAM - Myeloproliferative Neoplasm Assay Product Overview
  • Liaison IQ System
  • Liaison IQ System Product Overview
  • LIAISON NES System
  • LIAISON NES System Product Overview
  • LIAISON NES System - SARS-CoV-2 And Influenza A & B Test
  • LIAISON NES System - SARS-CoV-2 And Influenza A & B Test Product Overview
  • LIAISON NES System - SARS-CoV-2 And Influenza A & B Test Clinical Trial
  • LIAISON Quick Detect COVID TrimericS Ab Test
  • LIAISON Quick Detect COVID TrimericS Ab Test Product Overview
  • LIAISON XL - Chlamydia Pneumoniae Assay
  • LIAISON XL - Chlamydia Pneumoniae Assay Product Overview
  • LIAISON XL - Parvovirus B19 Test
  • LIAISON XL - Parvovirus B19 Test Product Overview
  • LIAISON XL- Procalcitonin Assay
  • LIAISON XL- Procalcitonin Assay Product Overview
  • LX200/FM3D Convalescent Serum - COVID-19
  • LX200/FM3D Convalescent Serum - COVID-19 Product Overview
  • LX200/FM3D Immunity Status - COVID-19
  • LX200/FM3D Immunity Status - COVID-19 Product Overview
  • Magpix - Ebola Virus Assay
  • Magpix - Ebola Virus Assay Product Overview
  • Magpix Convalescent Serum - COVID-19
  • Magpix Convalescent Serum - COVID-19 Product Overview
  • Magpix Serology Immunity Status - COVID-19
  • Magpix Serology Immunity Status - COVID-19 Product Overview
  • Magpix Syndromic Dx - COVID-19
  • Magpix Syndromic Dx - COVID-19 Product Overview
  • Meningitis Panel Assay
  • Meningitis Panel Assay Product Overview
  • Neisseria Meningitidis Assay
  • Neisseria Meningitidis Assay Product Overview
  • NxTAG Respiratory Pathogen Panel - Expanded Version
  • NxTAG Respiratory Pathogen Panel - Expanded Version Product Overview
  • Parvovirus B19 IFA Assay
  • Parvovirus B19 IFA Assay Product Overview
  • PML-RAR1 + ABL Assay
  • PML-RAR1 + ABL Assay Product Overview
  • PML-RAR2 + ABL Assay
  • PML-RAR2 + ABL Assay Product Overview
  • PML-RAR3 + ABL Assay
  • PML-RAR3 + ABL Assay Product Overview
  • Portable Field Deployed Diagnostic Tool
  • Portable Field Deployed Diagnostic Tool Product Overview
  • Progesterone II Assay
  • Progesterone II Assay Product Overview
  • Puckdx Molecular Diagnostic Test
  • Puckdx Molecular Diagnostic Test Product Overview
  • Quant ABL Assay
  • Quant ABL Assay Product Overview
  • Quant BCR-ABL p210 Assay
  • Quant BCR-ABL p210 Assay Product Overview
  • Reagent ASRs - Gastro-Intestinal Infections
  • Reagent ASRs - Gastro-Intestinal Infections Product Overview
  • Reagent ASRs - Genetic Disorders
  • Reagent ASRs - Genetic Disorders Product Overview
  • Reagent ASRs - Immuno-Compromised Disorders
  • Reagent ASRs - Immuno-Compromised Disorders Product Overview
  • Reagent ASRs - Infectious Disease
  • Reagent ASRs - Infectious Disease Product Overview
  • Reagent ASRs - Respiratory Disease
  • Reagent ASRs - Respiratory Disease Product Overview
  • Reagent ASRs - Vector-Borne Disease
  • Reagent ASRs - Vector-Borne Disease Product Overview
  • Simplexa Enterovirus Direct
  • Simplexa Enterovirus Direct Product Overview
  • Simplexa MRSA Direct
  • Simplexa MRSA Direct Product Overview
  • Verigene I Acute Dx - COVID-19
  • Verigene I Acute Dx - COVID-19 Product Overview
  • VERIGENE I SARS-CoV-2
  • VERIGENE I SARS-CoV-2 Product Overview
  • Verigene II Acute Dx - COVID-19
  • Verigene II Acute Dx - COVID-19 Product Overview
  • Verigene II Gastrointestinal Flex Assay
  • Verigene II Gastrointestinal Flex Assay Product Overview
  • Verigene II Gastrointestinal Flex Assay Clinical Trial
  • Verigene II Respiratory Flex Assay
  • Verigene II Respiratory Flex Assay Product Overview
  • VERIGENE II SARS-CoV-2
  • VERIGENE II SARS-CoV-2 Product Overview
  • Verigene II Syndromic Dx - COVID-19
  • Verigene II Syndromic Dx - COVID-19 Product Overview
  • Verigene II System
  • Verigene II System Product Overview
  • Verigene II System - Blood Culture ID Assay
  • Verigene II System - Blood Culture ID Assay Product Overview
  • Verigene II System - Meningitis Panel
  • Verigene II System - Meningitis Panel Product Overview
  • Verigene II System - Syndromic Assay
  • Verigene II System - Syndromic Assay Product Overview
  • xMAP-Powered Assay - Breast Cancer
  • xMAP-Powered Assay - Breast C

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Becton Dickinson and Co
  • bioMerieux SA
  • Quidel Corp
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics International Ltd
  • Sysmex Corp
  • Qiagen NV
  • Becton Dickinson and Co
  • Qiagen NV
  • Ortho Clinical Diagnostics Holdings Plc
  • Siemens Healthineers AG
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • Roche Diagnostics International Ltd
  • Sysmex Corp
  • bioMerieux SA
  • Thermo Fisher Scientific Inc
  • Ortho Clinical Diagnostics Holdings Plc
  • Danaher Corp
  • Bio-Rad Laboratories Inc